Skip to content
by Legal Desire
10 August 2022

Clifford Chance advises Highbridge and Whitebox on EUR 100m senior secured convertible facility for Mithra Pharmaceuticals

Advising firms

Deal team

16 lawyers named
LawyerFirmSeniorityPracticeOffice
Niek De Pauw Lead Clifford Chance Partner Corporate Brussels
Wim Aerts Lead Clifford Chance Counsel Global Financial Markets Brussels
Alexander Tanguy Clifford Chance Associate Not stated Not stated
Gillis Waelkens Clifford Chance Associate Not stated Not stated
Laurent Robert Clifford Chance Associate Not stated Not stated
Alexandre Ooms Clifford Chance Partner tax Not stated
Thomas Linard de Guertechin Clifford Chance Associate tax Not stated
Mateusz Chmura Clifford Chance Not stated Global Financial Markets Warsaw
Jaap Tempelman Clifford Chance Counsel Not stated Amsterdam
Andrei Mikes Clifford Chance Associate IP Amsterdam
Mark Gillgren Clifford Chance Partner Not stated Perth
Jacob Kahwaji Clifford Chance Partner Not stated Sydney
Cameron Reeves Clifford Chance Counsel Not stated Not stated
Kate Durham Clifford Chance Associate Not stated Not stated
Brianna Harcus Clifford Chance Associate Not stated Not stated
Nicholas Henneberry Clifford Chance Associate Not stated Not stated

13 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
EUR 100m (EUR 100m)
What the figure measures
Facility amount
Client
Highbridge Capital Management, LLC and Whitebox Advisors, LLCLenders
Counterparties
Mithra Pharmaceuticals (Borrower)